| pubmed-article:9814475 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C0021270 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C0560175 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C0241888 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C1705480 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C0011848 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C0231221 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C1706209 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:9814475 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:9814475 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:9814475 | pubmed:dateCreated | 1998-11-25 | lld:pubmed |
| pubmed-article:9814475 | pubmed:abstractText | Familial diabetes insipidus (FDI) is a syndrome of central vasopressin deficiency that is inherited in an autosomal dominant manner and that typically becomes clinically apparent in the first decade of life. Two novel mutations of the vasopressin gene have been identified in two previously unstudied kindreds with FDI. In each kindred, the inheritance of the FDI phenotype was consistent with an autosomal dominant mode of inheritance. In each proband, the diagnosis of central diabetes insipidus had been confirmed previously with a water deprivation protocol. After extraction of genomic DNA from each individual, the three exons of the vasopressin gene were separately amplified by PCR and directly sequenced using an automated dye termination method. In the proband and two other carriers of one kindred, a heterozygous C to T mutation was identified at nucleotide 1857. This is predicted to produce a serine to phenylalanine substitution at residue 56 of the vasopressin-related neurophysin peptide encoded by the mutated allele. The mutation also abolished an MspI site in the vasopressin sequence, and analysis of genomic DNA from eight members of the kindred (five with FDI) confirmed segregation of the mutation with the FDI phenotype. Another member of the kindred, a 13-month-old infant, also has the heterozygous C to T mutation, but a formal water balance study showed no evidence of diabetes insipidus. In the proband of the other kindred, a heterozygous G to A mutation was identified at nucleotide 1873. This mutation would be predicted to cause a cysteine to tyrosine substitution at residue 61 of the neurophysin encoded by the mutated allele. This heterozygous mutation was confirmed by the presence of an RsaI restriction site in one vasopressin allele in two members of the kindred. Therefore, two novel heterozygous mutations of the vasopressin gene have been identified in FDI kindreds. In one kindred, an asymptomatic carrier infant was identified and will require continued observation to determine whether she will develop clinical diabetes insipidus. The presence of these two novel mutations in a region of the vasopressin gene where other FDI mutations have been reported suggests that the part of the neurophysin peptide encoded by these sequences may be critically important in the appropriate expression of vasopressin. | lld:pubmed |
| pubmed-article:9814475 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9814475 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9814475 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9814475 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9814475 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9814475 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9814475 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9814475 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:9814475 | pubmed:issn | 0021-972X | lld:pubmed |
| pubmed-article:9814475 | pubmed:author | pubmed-author:AhmadiAA | lld:pubmed |
| pubmed-article:9814475 | pubmed:author | pubmed-author:MajzoubJ AJA | lld:pubmed |
| pubmed-article:9814475 | pubmed:author | pubmed-author:GrantF DFD | lld:pubmed |
| pubmed-article:9814475 | pubmed:author | pubmed-author:HosleyC MCM | lld:pubmed |
| pubmed-article:9814475 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9814475 | pubmed:volume | 83 | lld:pubmed |
| pubmed-article:9814475 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9814475 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9814475 | pubmed:pagination | 3958-64 | lld:pubmed |
| pubmed-article:9814475 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9814475 | pubmed:meshHeading | pubmed-meshheading:9814475-... | lld:pubmed |
| pubmed-article:9814475 | pubmed:meshHeading | pubmed-meshheading:9814475-... | lld:pubmed |
| pubmed-article:9814475 | pubmed:meshHeading | pubmed-meshheading:9814475-... | lld:pubmed |
| pubmed-article:9814475 | pubmed:meshHeading | pubmed-meshheading:9814475-... | lld:pubmed |
| pubmed-article:9814475 | pubmed:meshHeading | pubmed-meshheading:9814475-... | lld:pubmed |
| pubmed-article:9814475 | pubmed:meshHeading | pubmed-meshheading:9814475-... | lld:pubmed |
| pubmed-article:9814475 | pubmed:meshHeading | pubmed-meshheading:9814475-... | lld:pubmed |
| pubmed-article:9814475 | pubmed:meshHeading | pubmed-meshheading:9814475-... | lld:pubmed |
| pubmed-article:9814475 | pubmed:meshHeading | pubmed-meshheading:9814475-... | lld:pubmed |
| pubmed-article:9814475 | pubmed:meshHeading | pubmed-meshheading:9814475-... | lld:pubmed |
| pubmed-article:9814475 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9814475 | pubmed:articleTitle | Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant. | lld:pubmed |
| pubmed-article:9814475 | pubmed:affiliation | Endocrinology-Hypertension Division, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. grantf@a1.tch.harvard.edu | lld:pubmed |
| pubmed-article:9814475 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9814475 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9814475 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:551 | entrezgene:pubmed | pubmed-article:9814475 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9814475 | lld:pubmed |
